Fortrea (FTRE) Competitors $16.87 +0.02 (+0.12%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FTRE vs. OPCH, HIMS, SHC, SGRY, BTSG, LFST, CON, VCYT, ARDT, and GHShould you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include Option Care Health (OPCH), Hims & Hers Health (HIMS), Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), Veracyte (VCYT), Ardent Health Partners (ARDT), and Guardant Health (GH). These companies are all part of the "healthcare" industry. Fortrea vs. Option Care Health Hims & Hers Health Sotera Health Surgery Partners BrightSpring Health Services LifeStance Health Group Concentra Group Holdings Parent Veracyte Ardent Health Partners Guardant Health Option Care Health (NASDAQ:OPCH) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends. Is OPCH or FTRE more profitable? Option Care Health has a net margin of 4.37% compared to Fortrea's net margin of -10.09%. Option Care Health's return on equity of 15.30% beat Fortrea's return on equity.Company Net Margins Return on Equity Return on Assets Option Care Health4.37% 15.30% 6.57% Fortrea -10.09%1.98%0.78% Do analysts rate OPCH or FTRE? Option Care Health currently has a consensus target price of $30.83, suggesting a potential upside of 33.65%. Fortrea has a consensus target price of $23.60, suggesting a potential upside of 39.15%. Given Fortrea's higher probable upside, analysts plainly believe Fortrea is more favorable than Option Care Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Option Care Health 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Fortrea 1 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.25 Which has more volatility & risk, OPCH or FTRE? Option Care Health has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Fortrea has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Does the MarketBeat Community believe in OPCH or FTRE? Option Care Health received 43 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 60.23% of users gave Option Care Health an outperform vote while only 27.78% of users gave Fortrea an outperform vote. CompanyUnderperformOutperformOption Care HealthOutperform Votes5360.23% Underperform Votes3539.77% FortreaOutperform Votes1027.78% Underperform Votes2672.22% Does the media prefer OPCH or FTRE? In the previous week, Option Care Health had 38 more articles in the media than Fortrea. MarketBeat recorded 42 mentions for Option Care Health and 4 mentions for Fortrea. Option Care Health's average media sentiment score of 0.57 beat Fortrea's score of 0.25 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 17 Very Positive mention(s) 7 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in OPCH or FTRE? 98.1% of Option Care Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by company insiders. Comparatively, 0.1% of Fortrea shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger valuation & earnings, OPCH or FTRE? Option Care Health has higher revenue and earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOption Care Health$4.30B0.91$267.09M$1.1919.30Fortrea$3.11B0.49-$3.40M-$3.26-5.17 SummaryOption Care Health beats Fortrea on 17 of the 19 factors compared between the two stocks. Ad Investing Daily2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.Click here. Get Fortrea News Delivered to You Automatically Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTRE vs. The Competition Export to ExcelMetricFortreaMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.51B$2.59B$5.02B$8.42BDividend YieldN/A1.72%7.49%4.16%P/E Ratio-5.1732.22128.4816.64Price / Sales0.49262.861,723.1677.30Price / Cash6.76497.7736.9033.53Price / Book0.864.514.595.19Net Income-$3.40M-$31.39M$113.94M$223.67M7 Day Performance-4.43%0.22%110.64%2.76%1 Month Performance-10.38%-1.92%124.65%8.82%1 Year Performance-43.58%32.11%155.07%29.33% Fortrea Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTREFortrea3.2077 of 5 stars$16.87+0.1%$23.60+39.9%-43.6%$1.51B$3.11B-5.1718,000Upcoming EarningsOPCHOption Care Health4.9388 of 5 stars$30.15+2.4%$38.33+27.1%-15.7%$5.24B$4.59B25.347,802Analyst ForecastAnalyst RevisionNews CoverageGap DownHIMSHims & Hers Health2.6355 of 5 stars$23.10+6.3%$20.21-12.5%+214.0%$4.96B$872M288.791,046Gap UpSHCSotera Health2.6145 of 5 stars$15.83+2.9%$15.70-0.8%+20.1%$4.48B$1.05B113.073,000Upcoming EarningsSGRYSurgery Partners2.2117 of 5 stars$29.79+1.1%$39.63+33.0%+15.5%$3.79B$2.89B-110.3313,500Analyst ForecastBTSGBrightSpring Health Services2.002 of 5 stars$15.78+1.8%$16.05+1.7%N/A$2.70B$9.94B0.0035,000Earnings ReportAnalyst ForecastGap UpLFSTLifeStance Health Group1.1426 of 5 stars$6.93+1.2%$8.25+19.0%+11.5%$2.65B$1.16B-16.909,325Upcoming EarningsCONConcentra Group Holdings ParentN/A$20.81-0.5%$28.88+38.8%N/A$2.63B$1.86B0.0011,000Earnings ReportDividend AnnouncementAnalyst ForecastVCYTVeracyte4.2408 of 5 stars$34.12+3.3%$35.67+4.5%+40.3%$2.61B$399.58M-45.49790Upcoming EarningsARDTArdent Health PartnersN/A$18.00+1.5%$21.91+21.7%N/A$2.57B$5.63B0.0024,200Upcoming EarningsGHGuardant Health4.6129 of 5 stars$22.20+8.2%$40.31+81.6%-19.8%$2.51B$643.81M-5.431,779Upcoming Earnings Related Companies and Tools Related Companies OPCH Competitors HIMS Competitors SHC Competitors SGRY Competitors BTSG Competitors LFST Competitors CON Competitors VCYT Competitors ARDT Competitors GH Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FTRE) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTRE Stock Alerts